TerminatedNot Applicable

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

Stopped: COVID-19

United States9 participantsStarted 2019-04-16

Plain-language summary

This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pregnant women with singleton pregnancies, vertex presentation
✓. Age ≥ 18 years
✓. Healthy women ≥ 28 weeks gestation undergoing either Non-Stress test (NST) or Biophysical profile (BPP) OR
✓. Healthy women ≥ 37 weeks in labor
✓. Vertex presentation

Exclusion criteria

✕. Age \<18 years
✕. Multiple gestation ( twins, triplets)
✕. Presentation other than vertex
✕. \< 28 weeks of gestation

What they're measuring

Fetal signal integrity

Timeframe: During NST, BPP, or active labor

Trial details

NCT IDNCT04081623

SponsorRaydiant Oximetry, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-05-20

View on ClinicalTrials.gov More Fetal Distress trials